Prehospital Blood Transfusion Coalition: framework for EMS Blood Program Coordinator responsibilities

Abstract

Background

The success of prehospital blood transfusion programs depends not only on clinical guidelines and provider competencies but also on robust program coordination.

Methods

This guidance defines the scope and responsibilities of Emergency Medical Services (EMS) Blood Program Coordinators and Program Managers, in alignment with the AABB (American Association of Blood and Biotherapies) Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions, as well as the Prehospital Blood Transfusion Coalition (PHBTC) clinical practice guideline for civilian EMS. Coordinators oversee program implementation, regulatory compliance, operational logistics, and quality management under the supervision of the Transfusion Administration Service medical director.

Results

Responsibilities include validating storage and transport systems, ensuring continuous monitoring of blood components, standardizing education, and facilitating interagency collaboration. By formalizing this role, the guideline supports safe and consistent program operations across diverse EMS systems.

Conclusion

Collectively, the PHBTC series provides a structured framework to advance prehospital transfusion as a reliable, evidence-based intervention that improves outcomes for patients with life-threatening hemorrhage.

WHAT IS ALREADY KNOWN ON THIS TOPIC.

WHAT THIS STUDY ADDS

• This represents some of the first comprehensive guidance that formally defines and standardizes the operational Blood Program Coordinator role for prehospital emergency medical services (EMS) systems.

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

• This information provides EMS agencies with an operational blueprint for coordinator positions, reducing implementation variability and improving program quality across diverse systems.

Purpose

This clinical practice guideline (CPG) provides essential guidance for Emergency Medical Services (EMS) Blood Program Coordinators (‘Coordinators’) for prehospital EMS systems. This guideline supports the implementation, maintenance, and continuous improvement of prehospital blood transfusion programs through comprehensive education for coordinators, standardized processes, and quality management. This role requires a thorough understanding of clinical evidence, regulatory requirements, operational logistics, and coordination with multiple stakeholders across the healthcare continuum.

The coordinator serves as the EMS agency’s designee responsible for ensuring compliance with the American Association of Blood and Biotherapies (AABB) Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions (POHT) and all applicable federal, state, and local regulations. This role is critical for maintaining the quality system (AABB POHT Standard 1.2) under the supervision of the Transfusion Administration Service (TAS) medical director (AABB POHT Standard 1.1.1). The TAS is responsible for ensuring that containers used for handling, storing, and transporting blood and blood components are validated to maintain acceptable temperatures for the expected duration (AABB POHT Standard section 3). The TAS is also responsible for continuously monitoring and recording the temperature of blood and blood components during storage and transport. Prehospital transfusion programs are highly encouraged to have access to these standards for reference. This document is intended to accompany other prehospital transfusion coalition resources for the program, including the Prehospital Blood Transfusion Coalition (PHBTC)-CPG for civilian EMS.¹

Introduction

Prehospital blood transfusion programs involve a complex integration of clinical care, regulatory compliance, logistics, and system-wide coordination. These programs require alignment among EMS agencies, trauma systems, blood suppliers, and regulatory bodies to ensure the safe and timely delivery of blood products. Historically, each 10-minute delay in transfusion was associated with a 27% increase in odds of death, highlighting the critical importance of effective operations.² More contemporary data have shown that every 1-minute delay in prehospital resuscitation was associated with a 2% increase in the odds of 24-hour and 30-day mortality in both blunt and penetrating trauma.³ As adoption grows, variability in implementation and oversight remains a significant challenge. Given this complexity, the Blood Program Coordinator plays a vital role in operationalizing clinical evidence into safe, scalable, and compliant practice.

This CPG represents a living document intended to outline the core competencies, responsibilities, and best practices for Blood Program Coordinators. It is based on current evidence from landmark trials, including Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR)⁴ and Prehospital Plasma During Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock (PAMPer),⁵ and regulatory standards from the Food and Drug Administration (FDA) and AABB, as well as operational experience from established programs. The coordinator must possess both clinical understanding and administrative expertise to ensure the safe, effective, and compliant blood product administration programs in the prehospital setting.

These guidelines should be implemented in alignment with national standards, state regulations, local medical oversight, and regional/institutional policies. Successful programs require dedicated coordinator leadership to navigate complex regulatory environments, maintain stakeholder engagement, and drive continuous quality improvement as outlined in the THOR-AABB Working Party recommendations⁶ and the PHBTC-CPG for civilian EMS.¹

Core competencies and responsibilities

Foundational clinical knowledge

Clinical evidence

The coordinator must be familiar with the evidence base supporting prehospital transfusion, including understanding that hemorrhage remains the leading preventable cause of death following traumatic injury.⁷ Professional organizations have developed comprehensive position statements supporting prehospital hemorrhage control and blood product transfusion.⁸ Key studies demonstrate:

• Hemorrhage control is the leading preventable cause of trauma death, and most deaths occur within hours of injury.⁸

• Rapid hemorrhage control (including use of direct pressure, tourniquets, and/or hemostatic dressings) and the administration of tranexamic acid reduce blood loss and enable safer transfusion.⁹ Prehospital transfusion is most impactful when paired with immediate hemorrhage control, as it restores oxygen delivery and corrects coagulopathy before critical ischemia occurs.¹⁰

• PROPPR trial established the 1:1:1 ratio of plasma:platelets:red blood cells (RBCs) as optimal for trauma resuscitation and demonstrated a reduction in 24-hour mortality due to bleeding in the high ratio balanced transfusion group.²

• PAMPer trial showed 30-day mortality reduction from 33% to 23% with prehospital plasma, with secondary analysis providing additional insights into optimal resuscitation strategies.¹¹

• Combat experience: military data showing prehospital blood reduced 24-hour and 30-day mortality.¹²

• Time-critical nature: ‘Every Minute Matters’ study found an 11% increased mortality risk per minute delay of blood product administration.¹³

• Every 1-minute delay in prehospital resuscitation was associated with a 2% increase in the odds of 24-hour and 30-day mortality in both blunt and penetrating trauma.³

• Greater improvement in Shock Index (SI) and a reduction in early mortality have been observed in trauma patients who received prehospital whole blood transfusion.¹⁴

• Prehospital whole blood transfusion increased the probability of survival in trauma patients compared with transfusion within the first hour after hospital arrival.¹⁵

• A reduction in the use of massive transfusion protocols and an improvement in the SI were associated with prehospital whole blood transfusion in trauma patients.¹⁶

• Increases in unexpected survival: prehospital transfusion was associated with improved SI at emergency department (ED) presentation and an increase in unexpected survivors.¹⁷

• Safe and feasible: the PPOWER (Pragmatic Prehospital Type O Whole Blood Early Resuscitation) pilot trial demonstrated that low-titer O whole blood (LTOWB) is feasible and safe in the prehospital setting, with no documented transfusion reactions and no difference in 28-day mortality versus standard care.¹⁸

Blood product knowledge

Comprehensive understanding of blood products per AABB POHT Reference Standard 5.1.9A:

• LTOWB

  • Storage: 1–6°C (33.8–42.8°F) in storage, 1–10°C during transport.

  • Expiration: 21 days (CPD/CP2D) or 35 days (CPDA-1).

  • Volume: 450–600 mL per unit.

  • Anti-A/anti-B titers are typically <256.¹⁹

  • Contains all blood components in physiologic ratios and less overall citrate (preservative) than components.

  • Predominantly Rh positive due to the limited availability of Rh-negative donors.

• Plasma

  • Plasma products:

    • Fresh frozen plasma.

    • Liquid plasma.

    • Lyophilized plasma.

  • Storage: 1–6°C, expiration 26 days (CPD/CP2D) or 40 days (CPDA-1).

  • Volume: 200–300 mL per unit.

  • Additional storage formulations (including dried plasma) are a practical alternative when whole blood is unavailable.^{20 21}

  • Type AB or A (Rh immaterial) is typically used for emergency release.

• Packed RBCs

  • Storage: 1–6°C, expiration 42 days in additive solution.

  • Volume: 200–300 mL per unit.

  • O positive is typically used for emergency release.

• Cold-stored platelets

  • FDA approved for hemorrhage control.²²

  • Storage: 1–6°C without agitation, 14-day expiration.

  • An alternative is needed when room temperature platelets are impractical, as standard room temperature platelets have limited shelf life and need to be agitated for use, making them impractical for the prehospital environment.

• Leukoreduction

  • Leukoreduction is the process of filtering donated blood to remove most of the donor’s white blood cells before storage.

  • In the emergency release setting, RBCs and whole blood units in the USA are already prestorage leukoreduced, a step done at the blood center.

  • This decreases the risk of febrile non-hemolytic transfusion reactions, cytomegalovirus transmission, and human leukocyte antigen alloimmunization in recipients.^{23 24}

  • There is no evidence that leukoreduction improves outcomes in injured patients.²⁵

Regulatory compliance and oversight

Federal requirements

The coordinator must ensure compliance with multiple regulatory frameworks. Table 1 contains the key federal requirements.

Table 1. Key FDA regulatory requirements for emergency release and walking blood bank programs.

Regulatory citation	Applicability	Requirement summary
FDA 21 CFR 606.160(b)(3)(v)	Emergency release	Document physician authorization for emergency release, including a statement that ‘the clinical situation was sufficiently urgent to require release of uncrossmatched emergency-released blood before completion of compatibility testing’ (AABB Standard 5.4.3).
FDA 21 CFR 606.151(e)	Emergency release	Maintain required documentation for emergency release of blood and blood components.
FDA 21 CFR 606.171	All blood collection/transfusion	Report biological product deviations involving blood and blood components in accordance with FDA requirements.
FDA 21 CFR 606.170(b)	All blood collection/transfusion	Report any transfusion-related fatality to FDA within 7 days of becoming aware of the fatality.
FDA 21 CFR 610.40(f)	Laboratory/testing sites	Ensure registration of laboratories performing required infectious disease testing on blood donors and blood components.
FDA 21 CFR 610.46–47	All blood collection/transfusion	Implement look-back procedures and notification for donors and recipients associated with units potentially infected with certain infectious agents.
FDA 21 CFR 610.40(a)(2)(iii)(A)	Walking blood banks	For walking blood bank operations, follow alternative testing procedures as permitted under this provision.
FDA 21 CFR 610.120(a)	Walking blood banks	For walking blood bank operations, implement exceptions and alternative procedures as allowed under this provision, with appropriate documentation and approval.

AABB, American Association of Blood and Biotherapies; CFR, Code of Federal Regulations; FDA, Food and Drug Administration.

The coordinator ensures adherence to all applicable standards from the 1st Edition of the Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions, as highlighted in table 2.²⁶

Table 2. Key AABB Standards for Emergency Prehospital and Scheduled Out-of-Hospital Transfusions.

AABB Standard citation	Topic/applicability	Requirement summary
Standard 1.1.1	Medical director qualifications	TAS medical director must be qualified by education, training, and/or experience.
Standard 1.2	Quality system	A quality system must be implemented and maintained at all organizational levels.
Standards 3.0–3.6	Storage, transport, and transfusion equipment	Storage, transport, and transfusion equipment must be validated, traceable, and used in accordance with validated processes.
Standard 3.7	Computer-based transfusion tracking	Controls must be in place for any computer-based transfusion tracker, with an established alternative process if the system is unavailable.
Standard 3.8	Storage devices	Storage devices must have appropriate capacity, alarms, and temperature monitoring.
Standard 4.1.3	Testing laboratory requirements	Required testing must be performed by an AABB-accredited or equivalent laboratory.
Standard 5.1.8	Product identification and traceability	Blood components must be identifiable and traceable from source to final disposition.
Standard 6.2.9	Record retention	Records must be retained for specified timeframes (typically 5–10 years, depending on record type).
Standard 7.0	Deviations and adverse event management	All deviations and adverse events must be captured, assessed, investigated, and monitored.

AABB, American Association of Blood and Biotherapies; TAS, Transfusion Administration Service.

State and local compliance

Coordinators must navigate varying state and regional regulations regarding:

• Scope of practice for blood administration, including alternate provider as designated by the state and/or medical director.

• State-specific consent requirements.

• EMS protocol approval processes.

• Reporting requirements to state health departments.

• Integration with state trauma systems.

Data-informed program planning

Comprehensive needs assessment

The coordinator must conduct a thorough data analysis, including:

• Retrospective case analysis

  • Review of all cases where transfusion was requested but not performed (and why).

  • Review of all cases where a transfusion was performed.

  • Review of trauma cases meeting shock criteria (eg, systolic blood pressure (SBP) <90, heart rate (HR) >100, SI >1.0).

  • Review of medical hemorrhage cases (gastrointestinal bleeds, peripartum, ruptured aneurysms).

  • Calculate potential monthly usage based on historical data, while noting future regional-specific events that may affect this estimation.

• Time analysis

  • Map all transport times from 911 call to hospital arrival and patient transfer of care. Key intervals include:

    • Initial 911 call to the first patient contact.

    • Initial 911 call to the start of the transfusion.

    • First patient contact to the start of the transfusion.

    • Total scene time.

    • Transport time.

  • Identify cases where prehospital blood could have reduced the time to first unit in the hospital.

• Geographic distribution

  • Create heat maps combining trauma locations, transport times to the appropriate facility for definitive care, and fatality data.

  • NHTSA FARS data show that 40% of motor vehicle fatalities were alive when EMS arrived.²⁷

• Equity considerations

  • Analyze disparities in access to definitive hemorrhage control.

  • Consider shared inventory models and mutual aid/transport intercept options for resource-limited areas.

  • Address sex-based disparities in whole blood utilization.²⁸

  • Wilderness versus rural versus suburban versus urban disparities.

  • Potential religious considerations (such as Jehovah’s Witnesses).

Predictive modeling and resource allocation

Based on national data showing increasing prehospital blood use from 2020 to 2023¹⁵:

• Establish expected response model.

• Calculate units needed per vehicle/location per number of potential transports requiring administration.

• Plan for seasonal and regional variations (trauma season); include medical patients.

• Develop surge capacity (of EMS system, blood center, or trauma center) for mass casualty incidents (MCI).

• Model cost-effectiveness using lives saved estimates.

• Prehospital blood deployment models and dispatch practices (chase cars, supervisor vehicles, etc) to maximize program effectiveness.

Stakeholder engagement

Clinical leadership engagement

The coordinator must build relationships with key clinical partners:

• Trauma teams: coordinate with trauma surgeons on protocol development and outcome tracking per ACS-COT (American College of Surgeons Committee on Trauma) guidelines.

• Emergency medicine: align prehospital protocols with ED clinical leadership and EMS medical control physicians.

• Transfusion medicine: establish processes meeting AABB standards for emergency release and for post-transfusion follow-up.

• Specialty services:

  • OB/GYN for peripartum hemorrhage protocols.

  • Maternal-fetal medicine for female patients of childbearing potential who are Rh D antigen negative and have received LTO+WB.

  • Gastroenterology.

  • Vascular surgery

  • Nephrology (dialysis).

  • Hematology.

Operational partnerships

Build formal agreements addressing AABB POHT Standard 4.2.3 requirements:

• Blood suppliers

  • Establish supply agreements with rotation schedules.²⁹

  • Coordinate with regional blood centers on donor recruitment and blood drives.

  • Plan for shortage management protocols.

  • The ‘Bloody Transfusion Problem’ requires 90% more O-negative donors.³⁰

• Hospital partners

  • Develop data use agreements for outcome tracking.

  • Establish communication protocols for patient handoff.

  • Create processes for rotating unused blood (before expiration) per AABB POHT Standard 4.3.2.

  • Critical access hospitals may serve as blood distribution hubs.³¹

• EMS agencies

  • Coordinate ground and air medical services for operational considerations and handoff of care.

  • Use the same blood warmers to improve interoperability.

  • Develop mutual aid agreements for blood sharing.

  • Establish unified protocols across jurisdictions.

  • Coordinate with the blood supplier for efficient resupply of blood products after transfusion or rotation.

Community and public engagement

Develop comprehensive outreach strategies:

• Public education: partner with blood centers on donor awareness campaigns highlighting prehospital use and improved outcomes.

• Political partners and key stakeholders: engaging with local elected officials and key stakeholders can help with information dissemination, programmatic support and public messaging.

• Media relations: prepare messaging for program milestones, high-profile saves, and donor notification/appreciation communication.

• Faith-based dialogue:

  • Patients of various faith traditions may decline blood products and engage liaisons on advance directive recognition.

  • Develop protocols for the rapid identification of refusal documentation.

  • Respect religious autonomy with the emergency doctrine.³²

• Special populations:

  • Develop culturally sensitive materials in multiple languages.

  • Education to address concerns about Rh alloimmunization in women of childbearing potential.

  • Be familiar with organizations such as the Allo Hope Foundation for patient education.³³

Program development and integration

Clinical protocol development

Protocols must align with national guidelines while meeting local needs. The NAEMSP (National Association of EMS Physicians) has published comprehensive position statements and resource documents to guide protocol development for prehospital blood product transfusion.³⁴ The PHBTC has developed CPG for civilian EMS.⁶ Successful implementation requires careful attention to lessons learned from early adopting programs³⁵:

• Inclusion criteria (per PHBTC-CPG)¹

  • Adults: SBP <90 mm Hg or weak radial pulse, HR >100 unresponsive to fluids, SI >1.0.

  • Pediatrics: age-adjusted hypotension, tachycardia thresholds.

  • Clinical signs: altered mental status, delayed capillary refill, ETCO2 <25.

  • Paramedic intuition based on the patient’s physical presentation of hemorrhagic shock and/or patient history, coupled with scene details.

• Product selection algorithms

  • LTOWB as first line when available.

  • Component therapy (1:1 ratio) as an alternative, plasma for systems with limited whole blood access.

• Special considerations

  • Rh-positive blood in females of childbearing potential.

  • Pediatric weight-based dosing (10–20 mL/kg).

  • Trauma versus medical hemorrhage protocols, including whole blood use in non-trauma patients.³⁶

  • Integration with other advanced interventions.³⁷

  • Selective advanced resuscitative care strategies for non-compressible torso hemorrhage.³⁸

  • Bleeding disorders such as hemophilia.⁶

Consent process development

Create robust emergency consent procedures meeting regulatory requirements:

• Emergency doctrine application

  • Document implied consent per state law.

• Advance directive recognition

  • Train providers on identifying ‘No Blood’ cards.

  • Develop rapid assessment protocols, while not delaying care.

  • Document good faith efforts in patient care reports.

• Refusal of transfusion

  • Ensure processes are in place for the determination of capacity to make an informed decision to decline transfusion, including practices to sufficiently demonstrate the patient’s understanding of the risks associated with declining transfusion.

• Minor consent

  • Establish protocols for pediatric patients, including parental refusal scenarios and faith-based considerations.

Legal and risk management

Coordinate comprehensive legal review while following established roadmaps for removing common barriers to prehospital blood program implementation³⁹:

• Liability protection

  • Evaluate the scope of practice for EMS clinicians to ensure blood transfusion is included.

• Protocol authorization

  • Obtain appropriate medical control authority review of policy, procedures, and standing orders.

• Incident reporting

  • Develop workflows meeting FDA biological product deviation requirements.

• Sentinel event management

  • Create processes for immediate response, investigation, and notifications.

Inventory and logistics management

Blood supply chain coordination

Implement robust inventory management systems:

• PAR (Periodic Automatic Replacement) level establishment

  • Based on retrospective usage analysis.

  • Plan for 20–30% wastage in early implementation, with priority given to waste reduction measures.

  • Adjust based on actual utilization data.

  • National trends show increasing utilization during 2020–2023.¹⁸

• Rotation protocols

  • Establish first-in-first-out procedures.

  • Coordinate with hospital blood banks for rotation 7–14 days before expiration.

  • Track wastage metrics for continuous improvement.

  • Implement ‘golden day’ protocols for units approaching expiration to maximize the likelihood of utilization.

  • Consider the internal EMS system blood product rotation process, prioritizing resource stewardship.

• Distribution models

  • Fixed deployment on high-volume units.

  • Mobile blood banks for special events.

  • Cache systems at strategic locations.

  • Just-in-time delivery for planned transports.

  • MCI and/or disaster response.

• What to do with expired units

Cold chain management

Ensure compliance with AABB POHT Standard 3.8 requirements¹⁷:

• Storage equipment

  • Purpose-built cold storage systems for the prehospital environment are preferred.⁴⁰

  • Validate all containers (Standard 5.1.9.1).

  • Maintain 1–6°C storage temperature (Standard 5.1.9A).

  • Continuous monitoring with recordings every 4 hours (Standard 5.1.9.3).

  • Alarm activation allowing intervention time, with confirmation of notification receipt (Standard 3.8.1.1).

• Transport validation

  • Test containers under worst-case conditions.

  • Validate for maximum transport duration.

  • Document all validation studies per Standard 3.2.

  • Revalidate after any equipment changes.

• Temperature excursion management

  • Immediately quarantine the blood, destroy per established guideline.

  • Investigation within 24 hours.

  • Medical director review for disposition.

  • Documentation per Standard 3.5.2.

Documentation and data integration

Electronic medical record integration

Develop comprehensive documentation systems meeting AABB POHT Standard 6.0 requirements¹⁷:

• Electronic patient care record configuration

  • Create blood product administration modules.

  • Use the flow chart in addition to any site documentation procedure.

    • Two procedures:

      • Intravenous or intraosseous access.

      • Blood transfusion.

    • Document the blood product under the medication administration.

  • Include all required data elements per Standard 5.12.

  • Enable barcode scanning for product verification.

  • Implement forcing functions for critical fields.

• Required documentation elements

  • Two independent patient identifiers (Standard 5.5.1).

  • Product type, DIN, ABO/Rh (Standard 5.12).

  • Vital signs before, during, and after (Standard 5.3.7).

  • Consent type (implied/informed).

  • Transfusionist identification.

  • Transfusion reaction observed or adverse event noted.

• Real-time communication

  • Develop transfusion notification systems.

  • Create handoff tools, including standardized documentation of the process for receiving hospitals.

  • Implement image capture for product labels.

  • Ensure hospital blood bank integration.

Regulatory compliance documentation

Maintain records meeting retention requirements:

• 10-Year retention (per AABB POHT Standard 6.2.9A)

  • Policies, processes, procedures.

  • Equipment qualification records.

  • Blood product receipt and disposition.

  • Transfusion records and adverse events.

  • Temperature excursion investigations.

• 5-Year retention

  • Training and competency records.

  • Management reviews.

  • Risk assessments.

  • Agreement documents.

  • Quality indicator data.

Equipment and cold chain management (AABB POHT Standard 3.0)

Storage system management

Oversee comprehensive equipment programs:

• Cooler validation (Standard 3.2)

  • Installation qualification per the manufacturer.

  • Operational qualification before use.

  • Performance qualification in actual conditions.

  • Annual revalidation.

  • Post-repair requalification.

  • Appropriate ready reserve of equipment for program continuation during unanticipated front-line equipment compromise or maintenance.

• Temperature monitoring systems

  • Continuous monitoring capability.

  • Remote alarm notification.

  • Backup monitoring systems.

  • Closed-loop communication among appropriate stakeholders that an alarm was received and appropriate action was taken.

  • Calibration per Standard 3.5.1.

  • Data logging with audit trails.

• Warming devices (Standard 3.9)

  • FDA-approved devices only.

  • Temperature sensing with alarms.

  • Prevention of hemolysis.

  • Regular calibration.

  • Competency validation for users.

Administration equipment

Manage inventory and maintenance:

• Blood administration sets

  • 170–260 μm filters required (Standard 5.3.5).

  • Appropriate inventory levels.

  • Expiration date monitoring.

  • Storage condition compliance.

• Rapid infusion devices

  • FDA-approved devices only.

  • Preventive maintenance schedules.

  • Calibration documentation.

  • User competency validation.

Training and education coordination

Initial training program development

Create comprehensive curricula based on evidence:

• Core content ⁴¹

  • Hemorrhagic shock pathophysiology.

  • Damage control resuscitation principles.

  • Blood component characteristics.

  • Transfusion reaction recognition.

  • Equipment operation.

  • Documentation requirements.

• Delivery methods

  • Didactic sessions.

  • Hands-on skills labs.

  • High-fidelity simulation.

  • Case-based learning.

  • Just-in-time training tools.

• Competency validation (AABB POHT Standard 2.1.4)

  • Written knowledge assessment.

  • Practical skills demonstration.

  • Simulation-based testing.

  • Field observation checklist.

  • Documentation of competency.

Ongoing education programs

Maintain EMS clinician competency through:

• Requirements

  • Minimal annual (ideally, semiannual) skills verification.

  • Protocol updates.

  • Case review participation.

  • Transfusion reaction drills (recognition and management).

• Performance feedback

  • Individual provider metrics.

  • Documentation quality scores.

  • Protocol compliance rates.

  • Patient outcome data.

• Professional development

  • Conference attendance support.

  • Certification maintenance.

  • Research participation.

  • Peer teaching opportunities.

Quality assurance and improvement

Comprehensive monitoring program

Implement multifaceted quality systems per AABB POHT Standard 8.0:

• Case review process (Standard 8.1)

  • 100% review of all transfusions.

  • Multidisciplinary participation.

  • Root cause analysis for deviations.

  • Corrective action tracking.

• Key performance indicators

  • Time from 911 to transfusion.

  • Protocol compliance rates (target >95%).

  • Documentation completeness (target 100%).

  • Temperature excursion rate (<2%).

  • Product wastage rate (<20%).

  • Adverse event rate (benchmark <1%).

• Outcome metrics: national consensus standards such as the Standardized EMS Metrics for Survival in Transfusion and Advanced Resuscitation,⁴² including:

  • 24-hour and 30-day mortality.

  • Hospital length of stay.

  • Hospital blood product utilization.

  • ED disposition.

  • Injury Severity Score and Abbreviated Injury Scale.

  • Initial vital signs and SI at the hospital.

  • Potential future public health and economic metrics include cost per life saved and years of life saved.

Quality improvement initiatives

Drive continuous improvement through:

• Data analysis

  • Monthly dashboard reviews.

  • Quarterly stakeholder reports.

  • Annual program evaluation.

  • Benchmark comparisons.

• Process improvement (Standard 9.0)

  • Failure mode analysis.

  • Lean methodology application.

  • Rapid cycle improvements.

  • Best practice adoption.

• Research participation

  • Registry enrollment (NEMSIS, TQIP, regional trauma registries).

  • Collaborative research networks and data sets.

  • Publication of outcomes.

  • Conference presentations.

Program evaluation and sustainability

Comprehensive program assessment

Conduct periodic evaluations, including:

• Clinical impact analysis

  • Lives saved calculations.

  • Morbidity reduction.

  • Quality-adjusted life years.

  • National estimates suggest 1000+ lives saved annually.

• Financial analysis

  • Cost per life saved.

  • Revenue impact.

  • Resource utilization.

  • Return on investment.

• Stakeholder satisfaction

  • Hospital partner feedback.

  • Patient/family perspectives.

  • Community support assessment.

Sustainability planning

Develop long-term viability strategies:

• Funding diversification

  • Grant opportunities (federal, state, foundation, special populations such as rural health⁴³).

  • Hospital partnership agreements.

  • Insurance/Medicare/Medicaid advocacy.

  • Community fundraising.

• Innovation adoption

  • Dried plasma evaluation.

  • Drone delivery pilots.

  • Predictive analytics.

  • Artificial intelligence integration.

  • Cold chain storage technology advancements.

  • Walking blood bank programs.

• Workforce development

  • Succession planning.

  • Cross-training initiatives.

  • Leadership development.

  • Recruitment strategies.

Implementation timeline

Phase 1: foundation (months 1–3)

• Complete comprehensive needs assessment.

• Establish stakeholder working group.

• Develop project charter with executive sponsorship.

• Initiate regulatory review and legal consultation.

• Begin baseline data collection.

Phase 2: development (months 4–6)

• Finalize protocols with medical director approval.

• Execute blood supplier agreements.

• Complete equipment procurement and validation.

• Develop training curriculum and materials.

• Create documentation systems.

Phase 3: training (months 7–8)

• Conduct train-the-trainer sessions.

• Complete initial provider training cohorts.

• Validate individual competencies.

• Test all systems and processes.

• Conduct failure mode analysis.

Phase 4: launch (month 9)

• Initiate pilot with limited deployment.

• Monitor all processes intensively.

• Address issues in real time.

• Collect comprehensive feedback.

• Refine based on lessons learned.

Phase 5: sustainment (ongoing)

• Expand to full deployment.

• Implement continuous monitoring.

• Conduct quarterly reviews.

• Report outcomes publicly.

• Plan for program growth.

Quality metrics and reporting

Process metrics

• Training completion: 100% before patient contact.

• Protocol compliance: >95% adherence rate.

• Documentation accuracy: 100% required elements.

• Temperature compliance: <2% excursion rate.

• Product wastage: <20% in mature programs.

• On-time rotation: >95% before expiration.

Clinical metrics

• Time to transfusion: median <15 minutes from patient contact.

• SI improvement: >0.2 reduction post-transfusion.

• 24-hour mortality: target relative reduction versus historical controls.

• 30-day survival: align with PAMPer trial outcomes (23% 30-day mortality).

• Transfusion reactions: <1% acute reaction rate.

• Hospital utilization: reduced intensive care unit and total length of stay.

System metrics

• Geographic coverage: >90% of population served.

• Resource utilization: track units/patient and total usage.

• Cost-effectiveness analysis: <$50 000 per life saved.

Conclusion

The Blood Program Coordinator role is essential to successful prehospital transfusion program implementation and sustainability. Through mastery of clinical knowledge, regulatory requirements, operational logistics, and quality improvement, coordinators enable life-saving interventions at the point of injury or illness to improve patient outcomes. This guideline provides a framework for excellence in program coordination, supporting the delivery of evidence-based care that saves lives across diverse communities. As stated in the AABB Standards, “The goal of the Prehospital and Out-of-Hospital Standards is to maintain and enhance the quality and safety of prehospital and out-of-hospital transfusions.” The Blood Program Coordinator serves as the guardian of this mission.

The views expressed herein are those of the author(s) and do not necessarily reflect the official policy or position of any agencies under the US Government.

Data availability statement

No data are available.